You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
濟川藥業(600566.SH):品種蒲地藍消炎口服液、蛋白琥珀酸鐵口服溶液退出省級醫保目錄
格隆匯 12-28 16:40

格隆匯12月28日丨濟川藥業(600566.SH)公佈,隨着各省配套政策的執行、地方醫保目錄的調整,公司全資子公司濟川有限的品種蒲地藍消炎口服液、蛋白琥珀酸鐵口服溶液將於2022年12月31日前逐步調整出醫保支付範圍。

根據安徽省、陝西省、遼寧省省級單位醫保結算體系的相關要求,蒲地藍消炎口服液將於2022年12月31日調出省級醫保目錄。

根據安徽省、遼寧省省級單位醫保結算體系的相關要求,蛋白琥珀酸鐵口服溶液將於2022年12月31日調出省級醫保目錄。

本次調整後,公司主要品種蒲地藍消炎口服液、蛋白琥珀酸鐵口服溶液已調出所有省級醫保目錄。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account